A Study of the Effectiveness of Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants Ineligible for Standard Induction Therapy in Russian Federation

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

March 13, 2020

Primary Completion Date

February 16, 2023

Study Completion Date

February 16, 2023

Conditions
Acute Myeloid Leukemia (AML)
Trial Locations (10)

125284

Moscow State budget healthcare /ID# 218569, Moscow

191024

Russian Research Institute of Hematology and Transfusiology of the FMBA /ID# 229812, Saint Petersburg

197101

R.M.Gorbacheva Research Institute of Paediatric Oncology, Haematology and Transp /ID# 224831, Saint Petersburg

197341

Almazov National Medical Research Centre /ID# 218571, Saint Petersburg

400138

Hematology department State budgetary health care institution Volgograd region /ID# 229813, Volgograd

410012

Saratov State Medical University n.a. V.I. Razumovskiy /ID# 226059, Saratov

614077

Clinical Medico-Sanitary Unit #1 /ID# 222502, Perm

664049

Regional Clinical Hospital of Irkutsk /ID# 218570, Irkutsk

677008

Republican Hospital #1 - National Center of Medicine of Sakha (Yakutia) /ID# 224830, Yakutsk

693004

Sakhalin Regional Clinical Hospital /ID# 222501, Yuzhno-Sakhalinsk

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY